171 related articles for article (PubMed ID: 33945148)
1. Dexmedetomidine targets miR-146a and participates in the progress of chronic obstructive pulmonary disease in vivo and in vitro.
Li N; Li S; Wu Y; Xiong L; Li T; Xing D; Li Q; Wu D
Genes Genomics; 2021 Dec; 43(12):1371-1379. PubMed ID: 33945148
[TBL] [Abstract][Full Text] [Related]
2. [Alveolar macrophages in rats with chronic obstructive pulmonary disease (COPD) promotes proliferation, mucin and inflammatory factors secretion of airway epithelial cells and its mechanism].
Fan Y; Feng X; Zhu G; Zhang J; Dong Y; Bai C
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Jan; 39(1):1-8. PubMed ID: 36631008
[TBL] [Abstract][Full Text] [Related]
3. Tiao-bu-fei-shen formula promotes downregulation of the caveolin 1-p38 mapk signaling pathway in COPD - Associated tracheobronchomalacia cell model.
Zhou P; Yu W; Zhang C; Chen K; Tang W; Li X; Liu Z; Xia Q
J Ethnopharmacol; 2022 Jul; 293():115256. PubMed ID: 35367574
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine protected COPD-induced lung injury by regulating miRNA-146a.
Li N; Ouyang BS; Liu L; Lin CS; Xing DD; Liu J
Bratisl Lek Listy; 2016; 117(9):539-542. PubMed ID: 27677199
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine exerts cardioprotective effect through miR-146a-3p targeting IRAK1 and TRAF6 via inhibition of the NF-κB pathway.
He L; Wang Z; Zhou R; Xiong W; Yang Y; Song N; Qian J
Biomed Pharmacother; 2021 Jan; 133():110993. PubMed ID: 33220608
[TBL] [Abstract][Full Text] [Related]
6. Effects of dexmedetomidine pretreatment on rats with sepsis-induced acute kidney injury and miR-146a expression.
Ni J; He J; Kang L; Zhong Z; Wang L; Yin S
Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):93-98. PubMed ID: 32415933
[TBL] [Abstract][Full Text] [Related]
7. Expression of long non-coding RNA LUCAT1 in patients with chronic obstructive pulmonary disease and its potential functions in regulating cigarette smoke extract-induced 16HBE cell proliferation and apoptosis.
Zhao S; Lin C; Yang T; Qian X; Lu J; Cheng J
J Clin Lab Anal; 2021 Jul; 35(7):e23823. PubMed ID: 34125980
[TBL] [Abstract][Full Text] [Related]
8. Circulating miR-146a/b correlates with inflammatory cytokines in COPD and could predict the risk of acute exacerbation COPD.
Chen BB; Li ZH; Gao S
Medicine (Baltimore); 2018 Feb; 97(7):e9820. PubMed ID: 29443743
[TBL] [Abstract][Full Text] [Related]
9. MiR-31 aggravates inflammation and apoptosis in COPD rats via activating the NF-κB signaling pathway.
Wu H; Miao Y; Shang LQ; Chen RL; Yang SM
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9626-9632. PubMed ID: 33015806
[TBL] [Abstract][Full Text] [Related]
10. Baicalin Relieves Airway Inflammation in COPD by Inhibiting miR-125a.
Jing X; Huo J; Li L; Wang T; Xu J
Appl Biochem Biotechnol; 2024 Jun; 196(6):3374-3386. PubMed ID: 37656356
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA MEG3 regulates CSE-induced apoptosis and inflammation via regulating miR-218 in 16HBE cells.
Song B; Ye L; Wu S; Jing Z
Biochem Biophys Res Commun; 2020 Jan; 521(2):368-374. PubMed ID: 31668807
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy of dexmedetomidine on chronic obstructive pulmonary disease via downregulating lncRNA PACER.
Du XH; Li SS; Xiong GS; Yang GM; Shen W; Sun SB; Ye XL; Li L; Weng ZY
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12963-12970. PubMed ID: 33378047
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-α promotes airway mucus hypersecretion by repressing miR-146a-5p and miR-134-5p levels in human airway epithelial cells.
Fu HT; Zhang Y; Zhang P; Wu H; Sun XQ; Shen SY; Dou DB
Transl Cancer Res; 2021 Sep; 10(9):4047-4056. PubMed ID: 35116702
[TBL] [Abstract][Full Text] [Related]
14. MiR-3202 protects smokers from chronic obstructive pulmonary disease through inhibiting FAIM2: An in vivo and in vitro study.
Shen W; Liu J; Fan M; Wang S; Zhang Y; Wen L; Wang R; Wei W; Li N; Zhang Y; Zhao G
Exp Cell Res; 2018 Jan; 362(2):370-377. PubMed ID: 29208459
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of Tiaobu Feishen therapies on systemic and local inflammation responses in rats with stable chronic obstructive pulmonary disease.
Li JS; Li Y; Li SY; Wang YY; Deng L; Tian YG; Jiang SL; Wang Y
Zhong Xi Yi Jie He Xue Bao; 2012 Sep; 10(9):1039-48. PubMed ID: 22979936
[TBL] [Abstract][Full Text] [Related]
16. miR-146a-5p plays an essential role in the aberrant epithelial-fibroblast cross-talk in COPD.
Osei ET; Florez-Sampedro L; Tasena H; Faiz A; Noordhoek JA; Timens W; Postma DS; Hackett TL; Heijink IH; Brandsma CA
Eur Respir J; 2017 May; 49(5):. PubMed ID: 28546273
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological studies of the mechanism and function of interleukin-1beta-induced miRNA-146a expression in primary human airway smooth muscle.
Larner-Svensson HM; Williams AE; Tsitsiou E; Perry MM; Jiang X; Chung KF; Lindsay MA
Respir Res; 2010 Jun; 11(1):68. PubMed ID: 20525168
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-221-3p alleviates cell apoptosis and inflammatory response by targeting cyclin dependent kinase inhibitor 1B in chronic obstructive pulmonary disease.
Yang H; Zhang L; Wang Q
Bioengineered; 2021 Dec; 12(1):5705-5715. PubMed ID: 34516316
[TBL] [Abstract][Full Text] [Related]
19. miR-145-5p is associated with smoke-related chronic obstructive pulmonary disease via targeting KLF5.
Dang X; Yang L; Guo J; Hu H; Li F; Liu Y; Pang Y
Chem Biol Interact; 2019 Feb; 300():82-90. PubMed ID: 30639269
[TBL] [Abstract][Full Text] [Related]
20. The clinical value of lncRNA MALAT1 and its targets miR-125b, miR-133, miR-146a, and miR-203 for predicting disease progression in chronic obstructive pulmonary disease patients.
Liu S; Liu M; Dong L
J Clin Lab Anal; 2020 Sep; 34(9):e23410. PubMed ID: 32583510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
